Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
ORIGINAL ARTICLE  

 Article Access Statistics
    Viewed1251    
    Printed56    
    Emailed0    
    PDF Downloaded253    
    Comments [Add]    

Recommend this journal

Use of Arginine Vasopressin in the Management of Vasodilatory Shock After CABG - A Clinical Tria.


Department of Anaesthesiology, St. John's Medical College Hospital, Bangalore, India

Correspondence Address:
O P Sanjay
Department of Anaesthesiology, St. John's Medical College Hospital, Bangalore, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17827574

Rights and PermissionsRights and Permissions

Year : 2003  |  Volume : 6  |  Issue : 2  |  Page : 132-5

 

SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for

  Article in PDF (67 KB)
Email article
Print Article
Add to My List
Vasodilatory shock requiring treatment with catecholamines occurs in some patients following cardiopulmonary bypass. We investigated the use of vasopressin in the treatment of this syndrome. Forty patients with a left main coronary artery disease and a poor left ventricular function (ejection fraction <30%) were studied. Only those patients (n=12, 30%) in whom difficulty was experienced in maintaining a mean arterial pressure of > 60 mm Hg and a systemic vascular resistance of greater than 900 dynes.sec.cm5 on maximal doses of pharmacological and mechanical support were selected. Patients underwent a standard cardiac anaesthesia protocol. All patients had a Swan-ganz catheter inserted pre-operatively. Arginine vasopressin was administered as a bolus of 0.015 units/kg intravenously followed by an infusion of 0.03 units/kg/hour. This dose increased the mean arterial pressure from 67+/-7 to 95+/-5 mm Hg and the systemic vascular resistance from 860+/-55 to 1502+/-71 dynes.sec.cm-5. It was also associated with a decrease in pharmacological support. All subjects responded to vasopressin administration. Vasopressin is an effective pressor in vasodilatory shock after cardiopulmonary bypass.






[PDF]*
 

 

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 ORIGINAL ARTICLE
 




Department of Anaesthesiology, St. John's Medical College Hospital, Bangalore, India

Correspondence Address:
O P Sanjay
Department of Anaesthesiology, St. John's Medical College Hospital, Bangalore, India

Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17827574

Rights and PermissionsRights and Permissions

Vasodilatory shock requiring treatment with catecholamines occurs in some patients following cardiopulmonary bypass. We investigated the use of vasopressin in the treatment of this syndrome. Forty patients with a left main coronary artery disease and a poor left ventricular function (ejection fraction <30%) were studied. Only those patients (n=12, 30%) in whom difficulty was experienced in maintaining a mean arterial pressure of > 60 mm Hg and a systemic vascular resistance of greater than 900 dynes.sec.cm5 on maximal doses of pharmacological and mechanical support were selected. Patients underwent a standard cardiac anaesthesia protocol. All patients had a Swan-ganz catheter inserted pre-operatively. Arginine vasopressin was administered as a bolus of 0.015 units/kg intravenously followed by an infusion of 0.03 units/kg/hour. This dose increased the mean arterial pressure from 67+/-7 to 95+/-5 mm Hg and the systemic vascular resistance from 860+/-55 to 1502+/-71 dynes.sec.cm-5. It was also associated with a decrease in pharmacological support. All subjects responded to vasopressin administration. Vasopressin is an effective pressor in vasodilatory shock after cardiopulmonary bypass.






[PDF]*


        
Print this article     Email this article